IP Library Granted Patent US 8,236,053
Granted Patent B1
US 8,236,053 · App. 12/575,645 · Granted Aug 7, 2012

2-amino benzophenone UV-absorbers for ophthalmic lens materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,053
App. No.
12/575,645
Granted
Aug 7, 2012
Kind
B1
Abstract

Ophthalmic device materials comprising 2-amino benzophenone UV-absorbing compounds are disclosed. The ophthalmic device materials are particularly useful in intraocular lenses.

Claims (50)

1. A polymeric ophthalmic device material formed by polymerizing a composition comprising

a) 0.1 to 5% (w/w) of a UV absorber of formula (I):

wherein in formula (I):

R is H, C 1 -C 4 alkyl, —C(═O)C(═CH 2 )X, or —C(═O)O—(CH 2 ) n O—C(═O)C(═CH 2 )X;

n is 1-6;

X is H, CH 3 , or CH 2 CH 3 ;

Y 1 , Y 2 independently are H, Br, Cl, F, I, OCH 3 , NO 2 , —C(═O)C(═CH 2 )X, or —C(═O)O—(CH 2 ) n O—C(═O)C(═CH 2 )X; and

Y 3 is H, Br, Cl, F, I, OCH 3 , or NO 2 ;

provided that no more than one of R, Y 1 , and Y 2 may be —C(═O)C(═CH 2 )X or —C(═O)O—(CH 2 ) n O—C(═O)C(═CH 2 )X; and

b) a device-forming monomer selected from the group consisting of acrylic monomers and silicone-containing monomers.

2. The ophthalmic device material of claim 1 wherein in formula (I)

R is H or C 1 -C 4 alkyl;

n is 1-6;

X is H, CH 3 , or CH 2 CH 3 ;

Y 1 , Y 2 independently are H, Br, Cl, F, I, OCH 3 , NO 2 , —C(═O)C(═CH 2 )X, or —C(═O)O—(CH 2 ) n O—C(═O)C(═CH 2 )X; and

Y 3 is Br, Cl, F, I, OCH 3 , or NO 2 ;

provided that no more than one of Y 1 and Y 2 may be —C(═O)C(═CH 2 )X or —C(═O)O—(CH 2 ) n O—C(═O)C(═CH 2 )X.

3. The ophthalmic device material of claim 2 wherein in formula (I)

R is H or C 1 -C 4 alkyl;

n is 1-6;

X is H or CH 3 ;

Y 1 , Y 2 independently are H, Br, Cl, F, I, OCH 3 , NO 2 , —C(═O)C(═CH 2 )X, or —C(═O)O—(CH 2 ) n O—C(═O)C(═CH 2 )X; and

Y 3 is Cl;

provided that no more than one of Y 1 and Y 2 may be —C(═O)C(═CH 2 )X or —C(═O)O—(CH 2 ) n O—C(═O)C(═CH 2 )X.

4. The ophthalmic device material of claim 1 wherein the UV absorber is selected from the group consisting of: 2-amino benzophenone, 2-amino-5-chloro benzophenone, and 2-methylamino-5-chloro benzophenone.

5. The ophthalmic device material of claim 1 wherein the composition comprises from 0.1 to 4% (w/w) of the UV absorber.

6. The ophthalmic device material of claim 5 wherein the composition comprises from 1 to 3% (w/w) of the UV absorber.

7. The ophthalmic device material of claim 1 wherein the composition comprises a device-forming monomer of formula [V]:

where in formula [V]:

A is H, CH 3 , CH 2 CH 3 , or CH 2 OH;

B is (CH 2 ) m or [O(CH 2 ) 2 ] z ;

C is (CH 2 ) w ;

m is 2-6;

z is 1-10;

Y is nothing, O, S, or NR′, provided that if Y is O, S, or NR′, then B is (CH 2 ) m ;

R′ is H, CH 3 , C n′ H 2n′+1 (n′=1-10), iso-OC 3 H 7 , C 6 H 5 , or CH 2 C 6 H 5 ;

w is 0-6, provided that m+w≦8; and

D is H, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 6 H 5 , CH 2 C 6 H 5 or halogen.

8. The ophthalmic device material of claim 7 wherein in formula [V]:

A is H or CH 3 ;

B is (CH 2 ) m ;

m is 2-5;

Y is nothing or O;

w is 0-1; and

D is H.

9. The ophthalmic device material of claim 8 wherein the composition comprises a monomer selected from the group consisting of: 2-phenylethyl methacrylate, 4-phenylbutyl methacrylate, 5-phenylpentyl methacrylate, 2-benzyloxyethyl methacrylate, 3-benzyloxypropyl methacrylate, 2-phenylethyl acrylate, 4-phenylbutyl acrylate, 5-phenylpentyl acrylate, 2-benzyloxyethyl acrylate, and 3-benzyloxypropyl acrylate.

10. The ophthalmic device material of claim 1 wherein the composition comprises a cross-linking agent.

11. The ophthalmic device material of claim 1 wherein the composition comprises a reactive blue-light absorbing compound.

12. An ophthalmic device comprising an ophthalmic device material of claim 1 , wherein the ophthalmic device is selected from the group consisting of an intraocular lens, a contact lens, a keratoprosthesis, and a corneal inlay or ring.

13. The ophthalmic device of claim 12 wherein the ophthalmic device is an intraocular lens.

Assignments (4)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Jul 23, 2020
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 053293/0484 →
MERGER Recorded Jul 21, 2020
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 053273/0022 →
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2009
From: FREEMAN, CHARLES
To: ALCON RESEARCH, LTD
Reel/Frame 023344/0496 →